Nutex Health (NASDAQ:NUTX) Research Coverage Started at LADENBURG THALM/SH SH

LADENBURG THALM/SH SH initiated coverage on shares of Nutex Health (NASDAQ:NUTX) in a report released on Monday morning, Marketbeat.com reports. The firm issued a buy rating and a $336.00 price objective on the stock.

Several other research analysts also recently issued reports on the company. Wall Street Zen upgraded Nutex Health from a “hold” rating to a “buy” rating in a research report on Saturday, October 3rd. Zacks Research lowered Nutex Health from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. Lake Street Capital reiterated a “buy” rating and set a $310.00 target price (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. Weiss Ratings raised Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, October 6th. Finally, B. Riley Financial reissued a “buy” rating on shares of Nutex Health in a research report on Friday, September 4th. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, Nutex Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $323.67.

Nutex Health Price Performance

Shares of NASDAQ NUTX opened at $212.63 on Monday. The stock has a market cap of $1.46 billion, a price-to-earnings ratio of 8.35 and a beta of 0.55. Nutex Health has a 52 week low of $83.99 and a 52 week high of $226.16. The company’s 50-day moving average price is $202.62 and its 200 day moving average price is $150.48. The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59.

Nutex Health (NASDAQ:NUTX) last posted its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating the consensus estimate of $4.95 by $4.43. The firm had revenue of $210.75 million during the quarter, compared to the consensus estimate of $215.03 million. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. As a group, research analysts forecast that Nutex Health will post 27.58 earnings per share for the current fiscal year.

Insider Transactions at Nutex Health

In other Nutex Health news, Director Scott Saunders sold 203 shares of the company’s stock in a transaction dated Friday, September 18th. The shares were sold at an average price of $214.25, for a total value of $43,492.75. Following the transaction, the director directly owned 400 shares in the company, valued at approximately $85,700. This represents a 33.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 44.68% of the company’s stock.

Institutional Investors Weigh In On Nutex Health

Hedge funds have recently modified their holdings of the company. Allworth Financial LP raised its position in shares of Nutex Health by 41.0% in the second quarter. Allworth Financial LP now owns 203 shares of the company’s stock valued at $35,000 after buying an additional 59 shares during the last quarter. Sterling Capital Management LLC lifted its stake in shares of Nutex Health by 9.1% during the third quarter. Sterling Capital Management LLC now owns 1,771 shares of the company’s stock valued at $375,000 after buying an additional 148 shares during the period. Kilter Group LLC acquired a new stake in Nutex Health during the second quarter worth approximately $27,000. VIRGINIA RETIREMENT SYSTEMS ET Al boosted its position in Nutex Health by 3.8% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 5,500 shares of the company’s stock worth $1,164,000 after acquiring an additional 200 shares during the last quarter. Finally, Corient Private Wealth LP boosted its position in Nutex Health by 5.1% during the second quarter. Corient Private Wealth LP now owns 6,684 shares of the company’s stock worth $1,142,000 after acquiring an additional 325 shares during the last quarter. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.